ArticleDiabetology international2024

The efficacy of switching basal-bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching.

Toshihito Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.